Need Help? Call 1­-866-­796-­7386
« back to stock screener

  VTGN stock: Vistagen Therapeutics Inc

Current Rating
Strong Sell

Previous Rating:

Strong Sell
Our Stock Ratings
double the S&P500!
Learn more.
Company Statistics
Price
$1.90
Market Cap
22.1M
Sector
Health Care
Div. Growth
-
P/E
-
P/B
7.36
P/S
15.22
Dividend %
-
P/CF
3.1
P/FCF
-
Op. Cash Flow
-7.3K
FCF
-1.4
Op. Margin
-
Net Margin
-
ROE
-742.30%
ROI
-
ROA
-322.60%
EPS Growth
81.40%
Current Ratio
0.5
Debt/Equity
-
Company Price P/E Div. Yield Market Cap ($Mil) Rating
Fibrocell Science Inc (FCSC) $2.00 - - 31.3M Strong Buy
ProPhase Labs Inc (PRPH) $1.99 - - 34.7M Strong Buy
Eleven Biotherapeutics Inc (EBIO) $2.01 - - 47.5M Strong Buy
Zynex Inc. (ZYXI) $0.31 - - 10.3M Strong Buy
American Renal Associates Hold (ARA) $16.86 - - 706.6M Strong Buy
Find great stocks now!
Avoid risky stocks
Enter your favorite tickers and click “Get Ratings”

Disclaimer

Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.

All analysis relies on publicly available financial information. Learn More